Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Magdalena Sobieszczyk
Columbia University
Study Chair - Michael Yin
Columbia University
Study Chair - Scott Hammer
Columbia University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alabama Crs
Birmingham, Alabama, United States
- the Aids Research Alliance of America Crs
Los Angeles, California, United States
- Ucla Care Center Crs
Los Angeles, California, United States
- Bridge Hiv Crs
San Francisco, California, United States
- University of Colorado Hospital Crs
Aurora, Colorado, United States
- Orlando Immunology Center Crs
Orlando, Florida, United States
- the Hope Clinic of the Emory Vaccine Center Crs
Decatur, Georgia, United States
- Uic Project Wish Crs
Chicago, Illinois, United States
- Vrc Clinical Trials Core Crs
Bethesda, Maryland, United States
- Brigham and Women'S Hospital Vaccine Crs (bwh Vcrs)
Boston, Massachusetts, United States
- Fenway Health (fh) Crs
Boston, Massachusetts, United States
- Columbia P&s Crs
New York, New York, United States
- Ny Univ. Hiv/aids Crs
New York, New York, United States
- New York Blood Center Crs
New York, New York, United States
- University of Rochester Vaccines To Prevent Hiv Infection Crs
Rochester, New York, United States
- Case Clinical Research Site
Cleveland, Ohio, United States
- Penn Prevention Crs
Philadelphia, Pennsylvania, United States
- Vanderbilt Vaccine (vv) Crs
Nashville, Tennessee, United States
- University of Texas Southwestern Crs
Dallas, Texas, United States
- Baylor Vaccine Research Center Crs
Houston, Texas, United States
- Care-Id Crs
Annandale, Virginia, United States
- Seattle Vaccine and Prevention Crs
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2009
- Primary completion
- 6 Oct 2017
- Completion
- 6 Oct 2017
- Last update posted
- 15 Oct 2021
- Registered enrollment
- 2,504
- Registry id
- NCT00865566
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.